Get startedLog in
    Picture of Isofol Medical AB (publ) logo

    ISOFOL — Isofol Medical AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Isofol Receives Approval Of Biomarker Analysis Patent And Intention-To-Grant Patent Application For Study Dose Regimen In Europe

    Picture of Isofol Medical AB (publ) logoIsofol Medical AB (publ)
    26/07/2022 13:18
    July 26 (Reuters) - Isofol Medical AB (publ)  ISOFOL.ST :
    * ISOFOL RECEIVES APPROVAL OF BIOMARKER ANALYSIS PATENT AND
INTENTION-TO-GRANT PATENT APPLICATION FOR STUDY DOSE REGIMEN IN
EUROPE

Source text for Eikon:  ID:nPn4S479ta 
Further company coverage:  ISOFOL.ST 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Isofol Medical AB (publ)

    See all news